![Brian Culley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian Culley
Chief Executive Officer at
LINEAGE CELL THERAPEUTICS, INC.
Net worth: 339 836 $ as of 31/05/2026
Profile
Brian M.
Culley is currently President, Chief Executive Officer, CAO & Director at Lineage Cell Therapeutics, Inc. since 2022 and Chief Executive Officer at Asterias Biotherapeutics, Inc. since 2019.
Formerly, Mr. Culley was Chief Executive Officer & Director at Mast Therapeutics, Inc. from 2011 to 2017, Chief Executive Officer at Manuka, Inc. from 2017 to 2018, Chief Executive Officer & Director at Savara, Inc., Director at Orphagen Pharmaceuticals from 2017 to 2022, Director-Business Development & Marketing at iTherX Pharmaceuticals, Inc. from 2002 to 2004, and Licensing & Marketing Associate at the University of California, Berkeley from 1999 to 2000.
Education includes undergraduate studies at Boston College, graduate studies at the University of California, Santa Barbara, and an MBA from Johnson Graduate School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 20/04/2026 | 255,516 ( 0.1% ) | 339 836 $ | 31/05/2026 |
Brian Culley active positions
| Companies | Position | Start |
|---|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Chief Executive Officer | 17/09/2018 |
| ASTERIAS BIOTHERAPEUTICS INC | Chief Executive Officer | 08/03/2019 |
Former positions of Brian Culley
| Companies | Position | End |
|---|---|---|
Orphagen Pharmaceuticals
 Orphagen Pharmaceuticals Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Director/Board Member | 01/12/2022 |
| MANUKA, INC. | Chief Executive Officer | 17/09/2018 |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Chief Executive Officer | 28/04/2017 |
| SAVARA INC. | Chief Executive Officer | 27/04/2017 |
iTherX Pharmaceuticals, Inc.
 iTherX Pharmaceuticals, Inc. Medical DistributorsDistribution Services Engages in the discovery and development of drugs and therapies | Sales & Marketing | 01/01/2004 |
Training of Brian Culley
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
55
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Lineage Cell Therapeutics, Inc.
 Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
iTherX Pharmaceuticals, Inc.
iTherX Pharmaceuticals, Inc. Medical DistributorsDistribution Services Engages in the discovery and development of drugs and therapies | Distribution Services |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Health Technology |
Asterias Biotherapeutics, Inc.
 Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes regenerative medicine for neurology and oncology applications | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson Graduate School of Management
 Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orphagen Pharmaceuticals
Orphagen Pharmaceuticals Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Manuka, Inc.
 Manuka, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Savara, Inc.
 Savara, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals to treat respiratory diseases | Health Technology |
- Stock Market
- Insiders
- Brian Culley
